We are live on ! Find out more
A

AustralianSuper Portfolio holdings

AUM $23.1B
1-Year Est. Return 49.74%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+49.74%
3 Year Est. Return
+142.09%
5 Year Est. Return
+159.34%
10 Year Est. Return
AUM
$1.3B
AUM Growth
+$428M
Cap. Flow
+$378M
Cap. Flow %
29.05%
Top 10 Hldgs %
61.14%
Holding
31
New
7
Increased
13
Reduced
Closed
3

Top Buys

Rank Stock Value
1
AME icon
Ametek
AME
+$70.4M
2
TSM icon
TSMC
TSM
+$65.5M
3
ISRG icon
Intuitive Surgical
ISRG
+$62.7M
4
AYI icon
Acuity Brands
AYI
+$41.6M
5
HOG icon
Harley-Davidson
HOG
+$37.1M

Top Sells

Rank Stock Value
1
MJN
Mead Johnson Nutrition Company
MJN
+$24.2M
2
CSCO icon
Cisco
CSCO
+$23.6M
3
MDT icon
Medtronic
MDT
+$23.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.15%
2 Consumer Staples 20.06%
3 Healthcare 14.39%
4 Financials 12.31%
5 Industrials 11.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
1
Nike
NKE
$57.5B
$98.9M 7.6%
1,676,400
+561,900
+50% +$30.3M
INGR icon
2
Ingredion
INGR
$6.41B
$91.2M 7.01%
765,300
+305,300
+66% +$36.3M
HOG icon
3
Harley-Davidson
HOG
$2.88B
$88.1M 6.77%
1,631,400
+666,400
+69% +$37.1M
AMZN icon
4
Amazon
AMZN
$2.79T
$88.1M 6.77%
1,820,000
+144,000
+9% +$6.87M
AYI icon
5
Acuity Brands
AYI
$9.83B
$82.9M 6.37%
407,600
+235,600
+137% +$41.6M
AME icon
6
Ametek
AME
$53.7B
$72.4M 5.56%
+1,194,800
New +$70.4M
TMO icon
7
Thermo Fisher Scientific
TMO
$229B
$69.4M 5.33%
397,500
+73,500
+23% +$12.3M
C icon
8
Citigroup
C
$232B
$68.8M 5.29%
1,028,000
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.19T
$67.9M 5.22%
1,460,000
ISRG icon
10
Intuitive Surgical
ISRG
$131B
$67.8M 5.21%
+652,500
New +$62.7M
TSM icon
11
TSMC
TSM
$2.16T
$66.3M 5.09%
+1,895,700
New +$65.5M
V icon
12
Visa
V
$707B
$65.2M 5.01%
695,000
ORCL icon
13
Oracle
ORCL
$444B
$27.3M 2.1%
+545,000
New +$24.8M
PM icon
14
Philip Morris
PM
$290B
$27M 2.07%
229,800
MCO icon
15
Moody's
MCO
$87.3B
$26.2M 2.01%
215,200
ACN icon
16
Accenture
ACN
$118B
$25.8M 1.98%
208,500
+27,000
+15% +$3.29M
JNJ icon
17
Johnson & Johnson
JNJ
$671B
$25.7M 1.98%
194,500
TFCFA
18
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$25.7M 1.97%
+906,000
New +$26.1M
MO icon
19
Altria Group
MO
$116B
$24.9M 1.91%
334,300
+25,000
+8% +$1.83M
MSFT icon
20
Microsoft
MSFT
$3.79T
$24.9M 1.91%
360,800
PEP icon
21
PepsiCo
PEP
$191B
$24.6M 1.89%
+213,000
New +$24.4M
TWX
22
DELISTED
Time Warner Inc
TWX
$24.5M 1.88%
243,700
+11,000
+5% +$1.09M
PFE icon
23
Pfizer
PFE
$164B
$24.3M 1.87%
761,304
+21,080
+3% +$665K
K
24
DELISTED
Kellanova
K
$23.4M 1.8%
359,544
+14,910
+4% +$1M
MDLZ icon
25
Mondelez International
MDLZ
$78.4B
$23.3M 1.79%
539,400

Similar funds

AustralianSuper's Q2 2017 Portfolio in Review

As of Q2 2017, AustralianSuper held 31 positions worth $1.3B, up 49% from $873M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

AustralianSuper deployed $378M of net new capital in Q2 2017, opening 7 new positions and adding to 13 existing holdings. Its largest new stake was Ametek: 1,194,800 shares worth $72.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, down from 22% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the most notable exit was Mead Johnson Nutrition Company, an estimated $24.2M sold.

  • AustralianSuper's largest Q2 2017 buy was Ametek: 1,194,800 shares worth $72.4M.
  • AustralianSuper added most to Acuity Brands in Q2 2017, an estimated $41.6M increase.
  • AustralianSuper fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $24.2M.
  • AustralianSuper's ten largest holdings make up 61% of its $1.3B portfolio in Q2 2017.
  • AustralianSuper opened 7 new positions and closed 3 in Q2 2017.
  • AustralianSuper's portfolio value rose 49% quarter-over-quarter to $1.3B.

Based on AustralianSuper's 13F filing for Q2 2017, filed 15 Dec 2017.